Nanoscribe
A global leader in high-precision 3D microfabrication, providing laser-based 3D printers that enable sub-micrometer resolution for industrial and scientific applications.
- CEO / Founder
- Martin Hermatschweiler
- Team Size
- 100-150
- Stage
- Mature/Commercial Growth (Acquired by Lab14 GmbH in Nov 2024; formerly part of BICO Group)
- Total Funding
- $86,500,000
- Latest Round
- Acquisition (Divestment to Lab14 GmbH)
- Key Investors
- ["Lab14 GmbH","RSBG SE","BICO Group (Former)","ZEISS International (Former)"]
Technology & Products
Key Products
["Quantum X platform (High-speed microfabrication for micro-optics)","Quantum X bio (High-resolution 3D bioprinter for life sciences)","Quantum X align (High-precision alignment for fiber-to-chip coupling)","Photonic Professional GT2 (Versatile high-resolution 3D micro-printer)","IP-Resins (Proprietary photoresists and specialty printing materials)","Nanoscribe Nano-Print Solutions (Software and process support)"]
Technological Advantage
Proprietary Two-Photon Grayscale Lithography (2PGL) technology allows for ultra-smooth optical surfaces and high-speed voxel placement, significantly reducing production time compared to traditional 2PP methods.
Market & Competition
Target Customers
Research universities, government laboratories, and industrial R&D departments in photonics, medical device manufacturing, and micro-electronics.
Industry Verticals
["Micro-optics","Integrated Photonics","Life Sciences & Bioprinting","Micro-Electro-Mechanical Systems (MEMS)","Materials Science","Medical Technology"]
Competitors
["UpNano","Microlight3D","Heidelberg Instruments (Multiphoton Optics)","Boston Micro Fabrication (BMF)"]